Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosisYong Chul Kim(Seoul National University), Jung Pyo Lee(Seoul National University)Scientific ReportsSeptember 17, 201910.1038/s41598-019-49756-zCited by 24SaveCiteExport RISWatch citationsRelated PapersSoluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in Kidney|PLoS ONE|2012|45Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy|Scientific Reports|2018|14Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT|Scientific Reports|2023|14